Asia Pacific Radiopharmaceuticals Market Size to Hit USD 1.65 Billion by 2026

Asia Pacific Radiopharmaceuticals Market (By Radioisotope: Technetium-99m, Fluorine-18, Gallium-68, Iodine (I-131/I-123), and Others; By Application: Cancer, Cardiology, and Others; By Type: Diagnostic and Therapeutic; By End User: Hospitals & Clinics, Medical Imaging Centers, and Others) Industry Size, Share, Growth, Trends 2025-2035

Report Code : 1117 | Published : 25 May 2026 | Delivery : Immediate | Format : Excel | Author : Aditi Shivarkar, Aman Singh

Revenue,

USD 1.51 Bn

Forecast Year,

USD 3.64 Bn

CAGR, 2026 - 2035

9.20%

Report Coverage

Asia Pacific

Download Databook

The Asia Pacific radiopharmaceuticals market size surpassed USD 1.51 billion in 2025 and is predicted to reach around USD 3.64 billion by 2035, registering a CAGR of 9.2% from 2026 to 2035. Rising demand for advanced diagnostic and therapeutic services and growing prevalence of chronic diseases are boosting the market.

Asia Pacific Radiopharmaceuticals Market Statical Scope

Reports Attributes	Statistics
Market Size in 2025	USD 1.51 Billion
Market Size in 2026	USD 1.65 Billion
Market Size by 2035	USD 3.64 Billion
CAGR 2026 to 2035	9.2%
Base Year	2025
Forecast Period	2026 to 2035

In the Asia Pacific region, the radiopharmaceuticals market is growing due to expanding research and development activities, along with substantial resources allocated by governments and private entities to improve medical infrastructure. Enhancements in healthcare infrastructure and technology, including the development of PET /CT and SPECT systems, are facilitating better diagnostic capabilities.

Government support and favorable policies are also significantly promoting the use of radiopharmaceuticals. Innovations in molecular imaging and the adoption of advanced imaging techniques contribute to the market's expansion.

Asia Pacific Radiopharmaceuticals Market, By Radioisotope, 2025

Segments	Shares (%)
Technetium-99m	38%
Fluorine-18	24%
Gallium-68	12%
Iodine (I-131/I-123)	10%
Others	16%

Technetium-99m- Technetium-99m leads the segment, with a share of 38%, driven by its widespread use in diagnostic imaging and wide availability across healthcare facilities.
Fluorine-18- Fluorine-18 holds a significant portion, with a share of 24%, supported by increasing adoption in PET imaging, especially for oncology and neurological diagnostics.
Gallium-68- Gallium-68 represents a steady segment, with a share of 12%, supported by its growing use in targeted imaging for neuroendocrine tumors and precision diagnostics.

Asia Pacific Radiopharmaceuticals Market, By Application, 2025

Segments	Shares (%)
Cancer	52%
Cardiology	28%
Others	20%

Cancer - Cancer leads the segment, with a share of 52%, driven by the high prevalence of oncology cases and strong demand for early detection and targeted radiopharmaceutical-based diagnostics and therapies.
Cardiology - Cardiology holds a share of 28%, supported by the increasing use of nuclear imaging in diagnosing cardiovascular diseases.

Asia Pacific Radiopharmaceuticals Market, By Type, 2025

Segments	Shares (%)
Diagnostic	68%
Therapeutic	32%

Diagnostic - Diagnostic dominates the segment, with a share of 68%, driven by high demand for imaging procedures and early disease detection using radiopharmaceuticals.
Therapeutic - Therapeutic holds a share of 32%, supported by increasing adoption of targeted radionuclide therapies in cancer treatment.

Asia Pacific Radiopharmaceuticals Market, By End User, 2025

Segments	Shares (%)
Hospitals & Clinics	55%
Medical Imaging Centers	30%
Others	15%

Hospitals & Clinics - Hospitals & Clinics lead the segment, with a share of 55%, driven by high patient inflow and availability of advanced imaging and treatment infrastructure.
Medical Imaging Centers - Medical Imaging Centers hold a share of 30%, supported by increasing demand for specialized diagnostic imaging services.

Segment Covered in the Report

By Radioisotope

Technetium-99m
Fluorine-18
Gallium-68
Iodine (I-131/I-123)
Others

By Application

Cancer
Cardiology
Others

By Type

Diagnostic
Therapeutic

By End User

Hospitals & Clinics
Medical Imaging Centers
Others

List of Tables & Figures

List of Tables

• Table 1: Asia Pacific Radiopharmaceuticals Market Size, by Radioisotope, 2025-2035 (USD Billion)
• Table 2: Asia Pacific Radiopharmaceuticals Market Size, by Application, 2025-2035 (USD Billion)
• Table 3: Asia Pacific Radiopharmaceuticals Market Size, by Type, 2025-2035 (USD Billion)
• Table 4: Asia Pacific Radiopharmaceuticals Market Size, by End User, 2025-2035 (USD Billion)
• Table 5: Asia Pacific Radiopharmaceuticals Market Size, by Technetium-99m, 2025-2035 (USD Billion)
• Table 6: Asia Pacific Radiopharmaceuticals Market Size, by Fluorine-18, 2025-2035 (USD Billion)
• Table 7: Asia Pacific Radiopharmaceuticals Market Size, by Gallium-68, 2025-2035 (USD Billion)
• Table 8: Asia Pacific Radiopharmaceuticals Market Size, by Iodine (I-131/I-123), 2025-2035 (USD Billion)
• Table 9: Asia Pacific Radiopharmaceuticals Market Size, by Others (Radioisotope), 2025-2035 (USD Billion)
• Table 10: Asia Pacific Radiopharmaceuticals Market Size, by Cancer, 2025-2035 (USD Billion)
• Table 11: Asia Pacific Radiopharmaceuticals Market Size, by Cardiology, 2025-2035 (USD Billion)
• Table 12: Asia Pacific Radiopharmaceuticals Market Size, by Others (Application), 2025-2035 (USD Billion)
• Table 13: Asia Pacific Radiopharmaceuticals Market Size, by Diagnostic, 2025-2035 (USD Billion)
• Table 14: Asia Pacific Radiopharmaceuticals Market Size, by Therapeutic, 2025-2035 (USD Billion)
• Table 15: Asia Pacific Radiopharmaceuticals Market Size, by Hospitals & Clinics, 2025-2035 (USD Billion)
• Table 16: Asia Pacific Radiopharmaceuticals Market Size, by Medical Imaging Centers, 2025-2035 (USD Billion)
• Table 17: Asia Pacific Radiopharmaceuticals Market Size, by Others (End User), 2025-2035 (USD Billion)

List of Figures

• Figure 1: Asia Pacific Radiopharmaceuticals Market Share, by Radioisotope, 2025 (%)
• Figure 2: Asia Pacific Radiopharmaceuticals Market Share, by Application, 2025 (%)
• Figure 3: Asia Pacific Radiopharmaceuticals Market Share, by Type, 2025 (%)
• Figure 4: Asia Pacific Radiopharmaceuticals Market Share, by End User, 2025 (%)
• Figure 5: Asia Pacific Radiopharmaceuticals Market Forecast, 2025-2035 (USD Billion)
• Figure 6: Technetium-99m Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 7: Fluorine-18 Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 8: Gallium-68 Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 9: Iodine (I-131/I-123) Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 10: Others (Radioisotope) Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 11: Cancer Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 12: Cardiology Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 13: Others (Application) Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 14: Diagnostic Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 15: Therapeutic Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 16: Hospitals & Clinics Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 17: Medical Imaging Centers Segment Market Forecast, 2025-2035 (USD Billion)
• Figure 18: Others (End User) Segment Market Forecast, 2025-2035 (USD Billion)

Research Methodology

Related Databooks

March 2026